Literature DB >> 32914721

The Engaged Role of Tumor Microenvironment in Cancer Metabolism: Focusing on Cancer-Associated Fibroblast and Exosome Mediators.

Khandan Ilkhani1, Milad Bastami2, Soheila Delgir1, Asma Safi2, Shahrzad Talebian2, Mohammad-Reza Alivand2.   

Abstract

Metabolic reprogramming is a significant property of various cancer cells, which most commonly arises from the Tumor Microenvironment (TME). The events of metabolic pathways include the Warburg effect, shifting in Krebs cycle metabolites, and the rate of oxidative phosphorylation, potentially providing energy and structural requirements for the development and invasiveness of cancer cells. TME and tumor metabolism shifting have a close relationship through bidirectional signaling pathways between stromal and tumor cells. Cancer- Associated Fibroblasts (CAFs), as the most dominant cells of TME, play a crucial role in the aberrant metabolism of cancer. Furthermore, the stated relationship can affect survival, progression, and metastasis in cancer development. Recently, exosomes are considered one of the most prominent factors in cellular communications considering effective content and bidirectional mediatory effect between tumor and stromal cells. In this regard, CAF-Derived Exosomes (CDE) exhibit an efficient obligation to induce metabolic reprogramming for promoting growth and metastasis of cancer cells. The understanding of cancer metabolism, including factors related to TME, could lead to the discovery of a potential biomarker for diagnostic and therapeutic approaches in cancer management. This review focuses on the association between metabolic reprogramming and engaged microenvironmental, factors such as CAFs, and the associated derived exosomes. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  CAF-derived exosomes; Neoplasm metabolism; cancer-associated fibroblasts; exosomes; hypoxia; tumor microenvironment

Mesh:

Year:  2021        PMID: 32914721     DOI: 10.2174/1871520620666200910123428

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  10 in total

Review 1.  The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update.

Authors:  Zahra Torki; Davood Ghavi; Solmaz Hashemi; Yazdan Rahmati; Dara Rahmanpour; Majid Pornour; Mohammad Reza Alivand
Journal:  Cancer Chemother Pharmacol       Date:  2021-09-12       Impact factor: 3.333

Review 2.  Tumor endothelial cell-derived extracellular vesicles contribute to tumor microenvironment remodeling.

Authors:  Jian Gao; Xiaodong Zhang; Lei Jiang; Yan Li; Qianqian Zheng
Journal:  Cell Commun Signal       Date:  2022-06-25       Impact factor: 7.525

Review 3.  Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application.

Authors:  Fusheng Zhang; Haiyang Liu; Meiqi Duan; Guang Wang; Zhenghou Zhang; Yutian Wang; Yiping Qian; Zhi Yang; Xiaofeng Jiang
Journal:  J Hematol Oncol       Date:  2022-07-06       Impact factor: 23.168

Review 4.  Metabolic Reprogramming in Gastric Cancer: Trojan Horse Effect.

Authors:  Yu-Ling Bin; Hong-Sai Hu; Feng Tian; Zhen-Hua Wen; Mei-Feng Yang; Ben-Hua Wu; Li-Sheng Wang; Jun Yao; De-Feng Li
Journal:  Front Oncol       Date:  2022-01-12       Impact factor: 6.244

Review 5.  Exosome as a Delivery Vehicle for Cancer Therapy.

Authors:  Bohyun Moon; Suhwan Chang
Journal:  Cells       Date:  2022-01-18       Impact factor: 6.600

Review 6.  Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.

Authors:  Yifei Zhu; Xinyan Li; Lei Wang; Xiwei Hong; Jie Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-15       Impact factor: 6.055

Review 7.  Emerging innovations on exosome-based onco-therapeutics.

Authors:  Xiaofeng Dai; Yongju Ye; Fule He
Journal:  Front Immunol       Date:  2022-08-31       Impact factor: 8.786

8.  The expression of miR-513c and miR-3163 was downregulated in tumor tissues compared with normal adjacent tissue of patients with breast cancer.

Authors:  Soheila Delgir; Khandan Ilkhani; Asma Safi; Yazdan Rahmati; Vahid Montazari; Zahra Zaynali-Khasraghi; Farhad Seif; Milad Bastami; Mohammad Reza Alivand
Journal:  BMC Med Genomics       Date:  2021-07-07       Impact factor: 3.063

9.  The expression of miRNA-152-3p and miRNA-185 in tumor tissues versus margin tissues of patients with chemo-treated breast cancer.

Authors:  Asma Safi; Soheila Delgir; Khandan Ilkhani; Azam Samei; Seyyed Reza Mousavi; Zahra Zeynali-Khasraghi; Milad Bastami; Mohammad Reza Alivand
Journal:  BMC Res Notes       Date:  2021-06-16

Review 10.  Role of reactive oxygen species in tumors based on the 'seed and soil' theory: A complex interaction (Review).

Authors:  Wei Liang; Xinying He; Jianqiang Bi; Tingting Hu; Yunchuan Sun
Journal:  Oncol Rep       Date:  2021-07-30       Impact factor: 3.906

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.